A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), reported financial results ...

Nearly 4,000 participants came together on May 31 for We Walk UHNITED presented by Rogers, UHN Foundation's newest ...

In light of the significant drop in Regeneron’s stock price, a natural question emerges: is REGN now a viable buying ...

A Universal Search Experience That Brings Speed, Simplicity, and Context to Business Intelligence SAN FRANCISCO, CA / ACCESS ...

- The FDA grants Priority Review designation for the evaluation of medicines that, if approved, would provide a significant ...

Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring, ...

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

In alignment with the FDA’s aim to phase out petroleum-based dyes, the agency has approved three color additives from natural ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...